(NYSE: PRGO) Perrigo Co's forecast annual revenue growth rate of 1.49% is not forecast to beat the US Drug Manufacturers - Specialty & Generic industry's average forecast revenue growth rate of 4.59%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.87%.
Perrigo Co's revenue in 2025 is $4,326,000,000.On average, 3 Wall Street analysts forecast PRGO's revenue for 2025 to be $605,167,087,845, with the lowest PRGO revenue forecast at $600,364,622,139, and the highest PRGO revenue forecast at $612,381,105,114. On average, 3 Wall Street analysts forecast PRGO's revenue for 2026 to be $610,346,668,043, with the lowest PRGO revenue forecast at $602,420,109,380, and the highest PRGO revenue forecast at $620,360,908,326.
In 2027, PRGO is forecast to generate $623,452,394,157 in revenue, with the lowest revenue forecast at $619,406,083,597 and the highest revenue forecast at $630,542,036,562.